New Delhi, India, July 17, 2015 --(PR.com
)-- DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight’s Reports on gene therapy, PD-1/PDL-1, Antibody-Drug Conjugate (ADC) & CAR-T provides assessment over advancement in technologies, market trend, partnering & licensing opportunities, pipeline scenario and competitive landscape. In addition, the Oncology Reports will help to identify the key players of market and the potential market movers and barriers. After getting great response and feedback now they are planning to launch reports on Stem Cell Oncology, Bruton's Tyrosine Kinase (BTK) Inhibitors, TIM3, OX40, and LAG3.
The Oncology based Reports provides client with details on global cancer market. It comprehensively includes:
· R&D activities and technologies used along with the pipeline molecules in development.
· Information related to collaborations, in-licensing and out-licensing deals.
Stages of development of pipeline molecules.
· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.
DelveInsight’s Oncology reports help companies in understanding Oncology market dynamics and therefore giving opportunities for strategic alliance that will result in market penetration and enhancement of portfolios with optimal investment and maximal return. In addition, reports will assuage companies to detect specific tumors, determine genetic predisposition and biological response to cancer therapy.
For more information on Pipeline Insight Reports, email at info@delveInsight.com
DelveInsight Business Research
New Delhi-110075, India
Phone: +91-11-45689769, +91 9650213330
DelveInsight is a leading Business Consulting and Market Research Firm. We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this, DelveInsight also deals in providing custom research services in coherence with interest area of the clients.